These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15527846)

  • 1. Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge.
    Hunziker IP; Harkins S; Feuer R; Cornell CT; Whitton JL
    Virology; 2004 Dec; 330(1):196-208. PubMed ID: 15527846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
    Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
    Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice.
    Henke A; Chiang CS; Zell R; Stelzner A
    Antiviral Res; 2004 Nov; 64(2):131-6. PubMed ID: 15498609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
    Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
    Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.
    Park JH; Kim DS; Cho YJ; Kim YJ; Jeong SY; Lee SM; Cho SJ; Yun CW; Jo I; Nam JH
    Vaccine; 2009 Mar; 27(13):1974-83. PubMed ID: 19168108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation.
    M'hadheb-Gharbi MB; El Hiar R; Paulous S; Jaïdane H; Aouni M; Kean KM; Gharbi J
    J Mol Microbiol Biotechnol; 2008; 14(4):147-56. PubMed ID: 17693702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis.
    Fohlman J; Pauksen K; Morein B; Bjare U; Ilbäck NG; Friman G
    Scand J Infect Dis Suppl; 1993; 88():103-8. PubMed ID: 8390713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C3d enhances immune response to the secreted form of Coxsackie virus B3 VP1 DNA vaccine].
    Zhao N; Han XY; Wang XL; Li J; Li W; Xie LX; Li L; Wang YX
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2561-3. PubMed ID: 18067834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.
    Dan M; Chantler JK
    J Virol; 2005 Jul; 79(14):9285-95. PubMed ID: 15994822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
    Kim JY; Chung SK; Hwang HY; Kim H; Kim JH; Nam JH; Park SI
    Virus Res; 2007 Apr; 125(1):9-13. PubMed ID: 17222937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
    Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
    J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of Chinese herbal medicine Xin-Kang oral liquid on replication of CVB3 RNA in Coxsackievirus B3 infected mice].
    Wan SJ; Yang F; Huang XZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):238-40. PubMed ID: 17971932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.
    Henke A; Jarasch N; Wutzler P
    Expert Rev Vaccines; 2008 Dec; 7(10):1557-67. PubMed ID: 19053211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
    Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
    J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Yue Y; Xu W; Hu L; Jiang Z; Xiong S
    Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
    El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
    Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination procedures against Coxsackievirus-induced heart disease.
    Henke A; Jarasch N; Wutzler P
    Expert Rev Vaccines; 2003 Dec; 2(6):805-15. PubMed ID: 14711363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.